Forest Lab's Ceftazidime/avibactam Combination Receives Qualified Infectious Disease Product Designation from FDA

Forest Laboratories, Inc. (NYSE: FRX ), an international pharmaceutical manufacturer and marketer, today announced that the U.S. Food and Drug Administration (FDA) has designated its investigational drug, ceftazidime/avibactam,